SCHEMBL29469699

SCHEMBL29469699

CCOc1ccccc1S(=O)(=O)NC(=O)c1cc2ccc(N3CC4(CCC4)C3)cc2o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.40
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
KMT2A Q03164 3/20 0.35
LMNA P02545 3/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 3/20 0.35
HTT P42858 2/20 0.35
HPGD P15428 1/20 0.35
ALOX12 P18054 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TP53 P04637 1/20 0.34
DRD3 P35462 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
DRD2 P14416 2/20 0.34
DRD4 P21917 2/20 0.34
HTR1A P08908 2/20 0.34
HTR2A P28223 2/20 0.34
HTR2C P28335 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24334435 0.97 GAA (0.41) GAANPC1RAB9AKMT2ALMNA
SCHEMBL29469657 0.92 GAA (0.41) GAANPC1RAB9AKMT2ALMNA
SCHEMBL24334306 0.91 GAA (0.42) GAANPC1RAB9AKMT2ALMNA
SCHEMBL24333686 0.90 GAA (0.41) GAANPC1RAB9AKMT2ALMNA
SCHEMBL24333671 0.89 GAA (0.41) GAANPC1RAB9AKMT2ALMNA
SCHEMBL24334232 0.88 NPC1 (0.46) GAANPC1RAB9AKMT2ALMNA
SCHEMBL24334441 0.85 MAPT (0.48) GAANPC1RAB9AKMT2ALMNA
SCHEMBL24333782 0.85 GAA (0.41) GAANPC1RAB9AKMT2ALMNA
SCHEMBL24334290 0.84 GAA (0.41) GAANPC1RAB9AKMT2ALMNA
SCHEMBL24334431 0.83 GAA (0.40) GAANPC1RAB9AKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP claimed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed